Glaukos Corp Stock
Price
Target price
€159.00
€159.00
-2.450%
-4.0
-2.450%
-
14.08.26 / Stuttgart Stock Exchange
WKN: A14VCK / Name: Glaukos / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Glaukos Corp Stock
We can see a decrease in the price for Glaukos Corp. Compared to yesterday it has lost -€4.000 (-2.450%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Glaukos Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Glaukos Corp in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glaukos Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glaukos Corp | -2.450% | 10.884% | 21.642% | 115.894% | 68.912% | 143.284% | 297.561% |
| Penumbra Inc | -0.280% | 0.932% | 1.734% | 30.129% | 5.706% | 21.379% | 28.584% |
| CONMED Corp. | 0.460% | 0.943% | 17.582% | -8.547% | 22.286% | -58.039% | -59.238% |
| Integra LifeSciences Holdings Corp | 0.640% | 3.289% | -3.681% | 34.188% | 48.113% | -60.553% | -74.050% |
News
Glaukos Q2 Earnings Call Highlights
Key Points
- Interested in Glaukos Corporation? Here are five stocks we like better.
- Record Q2 sales: Glaukos reported $185.6 million in second-quarter revenue, up 50% year over year, driven by
Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now?
Alex R. Thurman, SVP & Chief Financial Officer of Glaukos Corporation (NYSE:GKOS), sold 10,000 shares of common stock on July 9, 2026, according to an SEC Form 4 filing.
Transaction value based on
